A Phase II Trial of Neoadjuvant PD-1 Vaccine PD1-Vaxx in Operable MSI High Colorectal Cancer
NCT06692959
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
44
Enrollment
OTHER
Sponsor class
Conditions
Colorectal Cancer
Interventions
DRUG:
PD-1 vaccine IMU-201 (PD1-Vaxx)
Sponsor
University of Southampton
Collaborators
[object Object]